Ventures III Lp Phase4 serves as Executive at ALBIREO PHARMA, INC., where they oversee executive responsibilities. Since joining the company, Ventures III Lp Phase4 has executed 2 insider transactions totaling $3.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 30, 2018 involved selling 98,500 shares valued at $3.4M.
Ventures III Lp Phase4 currently holds 1,066,947 shares of ALBIREO PHARMA, INC. (ALBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures III Lp Phase4 has been a net seller of ALBO stock. They have purchased $0 and sold $3.4M worth of shares.
Ventures III Lp Phase4's most recent insider trade was on Jan 30, 2018, when they sold 98,500 shares at $34.40 per share.
Get notified when new Form 4 filings are submitted
| $37.06 |
| Discretionary |